Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 565

1.

Pediatric Appropriate Evaluation Protocol for India (PAEP-India): Tool for Assessing Appropriateness of Pediatric Hospitalization.

Das MK, Arora NK, Poluru R, Seth A, Aggarwal A, Dubey AP, Goyal PC, Gathwala G, Malik A, Goel AK, Chakravarty A, Arya S, Upadhyay A, Gupta M, Mathew T, Pillai RK, Mathai J, Manivasagan S, Ramesh S, Aggarwal MK, Maure CG, Zuber PL.

Indian Pediatr. 2018 Dec 15;55(12):1041-1045.

PMID:
30745474
2.

An impedimetric biosensor for E. coli O157:H7 based on the use of self-assembled gold nanoparticles and protein G.

Lin D, Pillai RG, Lee WE, Jemere AB.

Mikrochim Acta. 2019 Feb 11;186(3):169. doi: 10.1007/s00604-019-3282-3.

PMID:
30741345
3.

Characteristics and outcomes of patients with metastatic KRAS mutant lung adenocarcinomas: The Lung Cancer Mutation Consortium experience.

El Osta B, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Sholl LM, Aisner DL, Bunn PA, Khuri FR, Ramalingam SS.

J Thorac Oncol. 2019 Feb 5. pii: S1556-0864(19)30097-8. doi: 10.1016/j.jtho.2019.01.020. [Epub ahead of print]

PMID:
30735816
4.

Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.

Martini DJ, Liu Y, Shabto JM, Lewis C, Kline MR, Collins H, Akce M, Kissick HT, Carthon BC, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, Master VA, El-Rayes BF, Ramalingam SS, Owonikoko TK, Harvey RD, Bilen MA.

Invest New Drugs. 2019 Feb 6. doi: 10.1007/s10637-019-00736-0. [Epub ahead of print]

PMID:
30725388
5.

Evaluation of the Statewide Variability in the Current Role of Different Specialties in Lower Extremity Endovascular Revascularization for Medicare Beneficiaries.

Roudsari B, Said M, Vu C, Pillai R.

J Vasc Interv Radiol. 2019 Feb;30(2):250-256.e1. doi: 10.1016/j.jvir.2018.10.029.

PMID:
30717959
6.

Pregnancy-associated respiratory failure in muscle specific kinase congenital myasthenic syndrome.

Wadwekar V, Pillai RR, Sesh S, Nair SS, Nair M.

Muscle Nerve. 2019 Jan 12. doi: 10.1002/mus.26410. [Epub ahead of print] No abstract available.

PMID:
30635923
7.

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen.

Ali H, Aldoss I, Yang D, Mokhtari S, Khaled S, Aribi A, Afkhami M, Al Malki MM, Cao T, Mei M, O'Donnell M, Salhotra A, Pullarkat V, Yang L, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pillai R, Snyder D.

Blood Adv. 2019 Jan 8;3(1):83-95. doi: 10.1182/bloodadvances.2018026658.

8.

METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.

Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, Lofgren SM, Hulea L, Tandoc K, Lu J, Li A, Nguyen ND, Caporicci M, Kim MP, Maitra A, Wang H, Wistuba II, Porco JA Jr, Bassik MC, Elias JE, Song J, Topisirovic I, Van Rechem C, Mazur PK, Gozani O.

Cell. 2019 Jan 24;176(3):491-504.e21. doi: 10.1016/j.cell.2018.11.038. Epub 2019 Jan 3.

PMID:
30612740
9.

Ionic-Liquid-Functionalized UiO-66 Framework: An Experimental and Theoretical Study on the Cycloaddition of CO2 and Epoxides.

Kurisingal JF, Rachuri Y, Pillai RS, Gu Y, Choe Y, Park DW.

ChemSusChem. 2019 Jan 4. doi: 10.1002/cssc.201802838. [Epub ahead of print]

PMID:
30610753
10.
11.

Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis

Stein Gold L, Bagel J, Lebwohl M, Lin T, Martin G, Pillai R.

J Drugs Dermatol. 2018 Dec 1;17(12):1290-1296.

PMID:
30586261
12.

Continuous Temperature-Monitoring Socks for Home Use in Patients With Diabetes: Observational Study.

Reyzelman AM, Koelewyn K, Murphy M, Shen X, Yu E, Pillai R, Fu J, Scholten HJ, Ma R.

J Med Internet Res. 2018 Dec 17;20(12):e12460. doi: 10.2196/12460.

13.

Transposon silencing in the Drosophila female germline is essential for genome stability in progeny embryos.

Durdevic Z, Pillai RS, Ephrussi A.

Life Sci Alliance. 2018 Sep 17;1(5):e201800179. doi: 10.26508/lsa.201800179. eCollection 2018 Oct.

14.

Fabrication and Thermoelectric Characterization of Transition Metal Silicide-Based Composite Thermocouples.

Yakaboylu GA, Pillai RC, Sabolsky K, Sabolsky EM.

Sensors (Basel). 2018 Nov 3;18(11). pii: E3759. doi: 10.3390/s18113759.

15.

Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.

Tyring SK, Kircik LH, Pariser DM, Guenin E, Bhatt V, Pillai R.

J Drugs Dermatol. 2018 Oct 1;17(10):1084-1091.

PMID:
30365589
16.

Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.

Green LJ, Kerdel FA, Cook-Bolden FE, Bagel J, Lin T, Martin G, Pillai R, Israel R, Ramakrishna T.

J Drugs Dermatol. 2018 Oct 1;17(10):1062-1069.

PMID:
30365586
17.
18.

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.

Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, El-Rayes BF, Master VA, Ramalingam SS, Owonikoko TK, Harvey RD.

Cancer. 2019 Jan 1;125(1):127-134. doi: 10.1002/cncr.31778. Epub 2018 Oct 17.

PMID:
30329148
19.

Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials.

Langley RG, Armstrong AW, Lebwohl MG, Blauvelt A, Hsu S, Tyring S, Rastogi S, Pillai R, Israel R.

Br J Dermatol. 2019 Feb;180(2):306-314. doi: 10.1111/bjd.17318. Epub 2018 Dec 27.

PMID:
30328108
20.

Exonuclease Domain-Containing 1 Enhances MIWI2 piRNA Biogenesis via Its Interaction with TDRD12.

Pandey RR, Homolka D, Olotu O, Sachidanandam R, Kotaja N, Pillai RS.

Cell Rep. 2018 Sep 25;24(13):3423-3432.e4. doi: 10.1016/j.celrep.2018.08.087.

21.

Acoustothermal Atomization of Water Nanofilms.

Pillai R, Borg MK, Reese JM.

Phys Rev Lett. 2018 Sep 7;121(10):104502. doi: 10.1103/PhysRevLett.121.104502.

PMID:
30240233
22.

Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis.

Lebwohl MG, Sugarman JL, Gold LS, Pariser DM, Lin T, Pillai R, Martin G, Harris S, Israel R.

J Am Acad Dermatol. 2019 Jan;80(1):282-285. doi: 10.1016/j.jaad.2018.09.002. Epub 2018 Sep 15. No abstract available.

23.
24.

Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.

Mendel M, Chen KM, Homolka D, Gos P, Pandey RR, McCarthy AA, Pillai RS.

Mol Cell. 2018 Sep 20;71(6):986-1000.e11. doi: 10.1016/j.molcel.2018.08.004. Epub 2018 Sep 6.

25.

Dynamics of Nanodroplets on Vibrating Surfaces.

Pillai R, Borg MK, Reese JM.

Langmuir. 2018 Oct 2;34(39):11898-11904. doi: 10.1021/acs.langmuir.8b02066. Epub 2018 Sep 19.

26.

Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination.

Stein Gold L, Kircik LH, Pariser D, Sugarman JL, Lin T, Kang R, Pillai R.

J Drugs Dermatol. 2018 Aug 1;17(8):863-868.

PMID:
30124725
27.

Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.

Sugarman JL, Weiss J, Tanghetti EA, Bagel J, Yamauchi PS, Stein Gold L, Lin T, Martin G, Pillai R, Israel R.

J Drugs Dermatol. 2018 Aug 1;17(8):855-861.

PMID:
30124724
28.

Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.

Press RH, Zhang C, Cassidy RJ, Ferris MJ, Zhong J, Steuer CE, Pillai RN, Owonikoko TK, Kahn S, Ramalingam SS, Patel PR, Curran WJ, Shu HG, Sica GL, Higgins KA.

Cancer. 2018 Sep 1;124(17):3586-3595. doi: 10.1002/cncr.31589. Epub 2018 Aug 18.

PMID:
30120912
29.

Nurse-led active surveillance for prostate cancer is safe, effective and associated with high rates of patient satisfaction-results of an audit in the East of England.

Martin E, Persaud S, Corr J, Casey R, Pillai R.

Ecancermedicalscience. 2018 Jul 25;12:854. doi: 10.3332/ecancer.2018.854. eCollection 2018.

30.

Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.

Aldoss I, Capelletti M, Park J, Pistofidis RS, Pillai R, Stiller T, Sanchez JF, Forman SJ, Ghobrial IM, Krishnan A.

Leukemia. 2019 Jan;33(1):266-270. doi: 10.1038/s41375-018-0213-y. Epub 2018 Jul 19.

PMID:
30026571
31.

Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.

Pariser DM, Green LJ, Stein Gold L, Sugarman JL, Lin T, Pillai R.

J Drugs Dermatol. 2018 Jul 1;17(7):723-726.

PMID:
30005093
32.

ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.

Petrossian K, Kanaya N, Lo C, Hsu PY, Nguyen D, Yang L, Yang L, Warden C, Wu X, Pillai R, Bernal L, Huang CS, Kruper L, Yuan Y, Somlo G, Mortimer J, Chen S.

Oncotarget. 2018 Jun 12;9(45):27736-27751. doi: 10.18632/oncotarget.25552. eCollection 2018 Jun 12.

33.

Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma.

Zhang XH, Nam S, Wu J, Chen CH, Liu X, Li H, McKeithan T, Gong Q, Chan WC, Yin HH, Yuan YC, Pillai R, Querfeld C, Horne D, Chen Y, Rosen ST.

J Invest Dermatol. 2018 Nov;138(11):2377-2387. doi: 10.1016/j.jid.2018.04.030. Epub 2018 Jul 14.

34.

Potential Racial Disparities Using Current Lung Cancer Screening Guidelines.

Annangi S, Nutalapati S, Foreman MG, Pillai R, Flenaugh EL.

J Racial Ethn Health Disparities. 2019 Feb;6(1):22-26. doi: 10.1007/s40615-018-0492-z. Epub 2018 May 4.

PMID:
29729002
35.

The effect of crystallite size on pressure amplification in switchable porous solids.

Krause S, Bon V, Senkovska I, Többens DM, Wallacher D, Pillai RS, Maurin G, Kaskel S.

Nat Commun. 2018 Apr 20;9(1):1573. doi: 10.1038/s41467-018-03979-2.

36.

Fine mapping of epistatic genetic determinants of blood pressure on rat chromosome 5.

Waghulde H, Pillai R, Cheng X, Nie Y, Mell B, Joe B.

J Hypertens. 2018 Jul;36(7):1486-1491. doi: 10.1097/HJH.0000000000001732.

PMID:
29634662
37.

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.

Gold LS, Lebwohl MG, Sugarman JL, Pariser DM, Lin T, Martin G, Pillai R, Israel R, Ramakrishna T.

J Am Acad Dermatol. 2018 Aug;79(2):287-293. doi: 10.1016/j.jaad.2018.03.040. Epub 2018 Apr 1.

38.

Metal-Organic Frameworks for Cultural Heritage Preservation: The Case of Acetic Acid Removal.

Dedecker K, Pillai RS, Nouar F, Pires J, Steunou N, Dumas E, Maurin G, Serre C, Pinto ML.

ACS Appl Mater Interfaces. 2018 Apr 25;10(16):13886-13894. doi: 10.1021/acsami.8b02930. Epub 2018 Apr 11.

PMID:
29613759
39.

Immunochromatography in CSF improves data on surveillance of S. pneumoniae meningitis in India.

Jayaraman Y, Mehendale S, Jayaraman R, Varghese R, Chethrapilly Purushothaman GK, Rajkumar P, Sukumar B, Pillai RK, Mohan G, Radhakrishnan DN, Sridharan S, Babu N, Ganesapillai M, Rao SP, Kar SK, Manchanda V, Kanga A, Verghese VP, Veeraraghavan B.

J Infect Public Health. 2018 Sep - Oct;11(5):735-738. doi: 10.1016/j.jiph.2018.01.002. Epub 2018 Mar 30.

40.

Throwing More Cold Water on Heat Shock Protein 90 Inhibitors in NSCLC.

Pillai RN, Ramalingam SS.

J Thorac Oncol. 2018 Apr;13(4):473-474. doi: 10.1016/j.jtho.2018.02.010. No abstract available.

PMID:
29576286
41.

Molecular connectivity disruptions in males with major depressive disorder.

Pillai RL, Zhang M, Yang J, Mann JJ, Oquendo MA, Parsey RV, DeLorenzo C.

J Cereb Blood Flow Metab. 2018 Mar 9:271678X18764053. doi: 10.1177/0271678X18764053. [Epub ahead of print]

PMID:
29519187
42.

Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials.

Gottlieb AB, Gordon K, Hsu S, Elewski B, Eichenfield LF, Kircik L, Rastogi S, Pillai R, Israel R.

J Eur Acad Dermatol Venereol. 2018 Mar 6. doi: 10.1111/jdv.14913. [Epub ahead of print]

PMID:
29512200
43.

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3.

Papp KA, Gordon KB, Langley RG, Lebwohl MG, Gottlieb AB, Rastogi S, Pillai R, Israel RJ.

Br J Dermatol. 2018 Aug;179(2):320-328. doi: 10.1111/bjd.16464. Epub 2018 May 23.

PMID:
29488226
44.

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.

Zhao X, Zhang Z, Moreira D, Su YL, Won H, Adamus T, Dong Z, Liang Y, Yin HH, Swiderski P, Pillai RK, Kwak L, Forman S, Kortylewski M.

Mol Ther. 2018 Mar 7;26(3):695-707. doi: 10.1016/j.ymthe.2018.01.007. Epub 2018 Jan 17.

45.

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Hashimoto M, Kamphorst AO, Im SJ, Kissick HT, Pillai RN, Ramalingam SS, Araki K, Ahmed R.

Annu Rev Med. 2018 Jan 29;69:301-318. doi: 10.1146/annurev-med-012017-043208.

PMID:
29414259
46.

Oral Health and Brain Injury: Causal or Casual Relation?

Pillai RS, Iyer K, Spin-Neto R, Kothari SF, Nielsen JF, Kothari M.

Cerebrovasc Dis Extra. 2018;8(1):1-15. doi: 10.1159/000484989. Epub 2018 Jan 9. Review.

47.

Soft Tissue Rosai-Dorfman Disease: Case report.

Rajib RC, Pillai R, Sulaiman IA, Al-Haddabi I.

Sultan Qaboos Univ Med J. 2017 Nov;17(4):e452-e454. doi: 10.18295/squmj.2017.17.04.012. Epub 2018 Jan 10.

48.

Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?

Pillai RLI, Zhang M, Yang J, Boldrini M, Mann JJ, Oquendo MA, Parsey RV, DeLorenzo C.

Depress Anxiety. 2018 May;35(5):411-420. doi: 10.1002/da.22721. Epub 2018 Jan 24.

PMID:
29365217
49.

Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61 229 individuals in 21 countries.

Palafox B, Goryakin Y, Stuckler D, Suhrcke M, Balabanova D, Alhabib KF, Avezum A, Bahonar A, Bai X, Chifamba J, Dans AL, Diaz R, Gupta R, Iqbal R, Ismail N, Kaur M, Keskinler MV, Khatib R, Kruger A, Kruger IM, Lanas F, Lear SA, Li W, Liu J, Lopez-Jaramillo P, Peer N, Poirier P, Rahman O, Pillai RK, Rangarajan S, Rosengren A, Swaminathan S, Szuba A, Teo K, Wang Y, Wielgosz A, Yeates KE, Yusufali A, Yusuf S, McKee M.

BMJ Glob Health. 2017 Dec 17;2(4):e000443. doi: 10.1136/bmjgh-2017-000443. eCollection 2017.

50.

Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.

Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, Mann JJ, Oquendo MA, Parsey RV, DeLorenzo C.

Hum Brain Mapp. 2018 Feb;39(2):1043-1055. doi: 10.1002/hbm.23903. Epub 2017 Nov 27.

Supplemental Content

Loading ...
Support Center